Antigen-specific B-1a antibodies induced by Francisella tularensis LPS provide long-term protect i on aga i nst F. tularensis LVS challenge

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 11, 2009, Pages 4343-4348

  Cole, Leah E ^a   Yang, Yang ^b   Elkins, Karen L ^c   Fernandez, Ellen T ^c   Qureshi, Nilofer ^d   Shlomchik, Mark J ^e   Herzenberg, Leonard A ^b   Herzenberg, Leonore A ^b   Vogel, Stefanie N ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^d UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; B 1A ANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN HEAVY CHAIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; FRANCISELLA TULARENSIS; HUMORAL IMMUNITY; IMMUNOGLOBULIN PRODUCTION; IMMUNOSTIMULATION; INFECTION RESISTANCE; MALE; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; PROVOCATION TEST; T LYMPHOCYTE; TRANSGENIC MOUSE; TULAREMIA; WILD TYPE;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; ANTIGENS, BACTERIAL; B-LYMPHOCYTES; BACTERIAL VACCINES; FRANCISELLA TULARENSIS; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; TULAREMIA;

BACTERIA (MICROORGANISMS); FRANCISELLA TULARENSIS; MUS; MUS MUSCULUS; NEGIBACTERIA;

EID: 63149155642     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0813411106     Document Type: Article

References (33)

1. Dennis DT, et al. (2001) Tularemia as a biological weapon: Medical and public health management. JAMA 285:2763-2773.
2. Elkins KL, Cowley SC, Bosio CM (2003) Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain Microbes Infect 5:135-142.
3. Borghesi L, Milcarek C (2007) Innate versus adaptive immunity: A paradigm past its prime? Cancer Res 67:3989-3993.
4. Baumgarth N, Tung JW, Herzenberg LA (2005) Inherent specificities in natural antibodies: A key to immune defense against pathogen invasion. Springer Semin Immu-nopathol 26:347-362.
5. Miller C, Stedra J, Kelsoe G, Cerny J (1995) Facultative role of germinal centers and T cells in the somatic diversification of IgVH genes. J Exp Med 181:1319-1331.
6. + antibodies) are produced by peritoneal CD5+ B lymphocytes. Int Immunol 2:515-520.
7. Cole LE, et al. (2006) Immunologic consequences of Francisella tularensis Live Vaccine Strain Infection: Role of the innate immune response in infection and immunity. J Immunol 176:6888-6899.
8. Dreisbach VC, Cowley S, Elkins KL (2000) Purified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induces protective immunity against LVS infection that requires B cells and gamma interferon. Infect Immun 68:1988-1996.
9. Chen J, et al. (1993) Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus. Int Immunol 5:647-656.
10. Hannum LG, Haberman AM, Anderson SM, Shlomchik MJ (2000) Germinal center initiation, variable gene region hypermutation, and mutant B cell selection without detectable immune complexes on follicular dendritic cells. J Exp Med 192:931-942.
11. Hashimoto S, et al. (1999) Identification of the SH2 domain binding protein of Bruton's tyrosine kinase as BLNK-functional significance of Btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling. Blood 94:2357-2364.
12. Khan WN, et al. (1995) Defective B cell development and function in Btk-deficient mice. Immunity 3:283-299.
13. Rawlings DJ, et al. (1993) Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 261:358-361.
14. Fulop M, Mastroeni P, Green M, Titball RW (2001) Role of antibody to lipopolysaccha-ride in protection against low-and high-virulence strains of Francisella tularensis. Vaccine 19:4465-4472.
15. Bos NA, et al. (1987) Early development of Ig-secreting cells in young of germ-free BALB/c mice fed a chemically defined ultrafiltered diet. Cell Immunol 105:235-245.
16. Hooijkaas H, Benner R, Pleasants JR, Wostmann BS (1984) Isotypes and specificities of immunoglobulins produced by germ-free mice fed chemically defined ultrafiltered ''antigen-free'' diet. Eur J Immunol 14:1127-1130.
17. Kenny JJ, Yaffe LJ, Ahmed A, Metcalf ES (1983) Contribution of Lyb 5+ and Lyb 5-B cells to the primary and secondary phosphocholine-specific antibody response. J Immunol 130:2574-2579.
18. Haas KM, Poe JC, Steeber DA, Tedder TF (2005) B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 23:7-18.
19. Alugupalli KR, et al. (2003) The resolution of relapsing fever borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes. JImmunol 170:3819-3827.
20. Yang Y, Tung JW, Ghosn EE, Herzenberg LA, Herzenberg LA (2007) Division and differentiation of natural antibody-producing cells in mouse spleen. Proc Natl Acad Sci USA 104:4542-4546.
21. Gunn JS, Ernst RK (2007) The structure and function of Francisella lipopolysaccharide. Ann NY Acad Sci 1105:202-218.
22. Gavin AL, et al. (2006) Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling. Science 314:1936-1938.
23. Pasare C, Medzhitov R (2005) Control of B-cell responses by Toll-like receptors. Nature 438:364-368.
24. Meyer-Bahlburg A, Khim S, Rawlings DJ (2007) B cell intrinsic TLR signals amplify but are not required for humoral immunity. J Exp Med 204:3095-3101.
25. Genestier L, et al. (2007) TLR agonists selectively promote terminal plasma cell differentiation of B cell subsets specialized in thymus-independent responses. JImmunol 178:7779-7786.
26. Gururajan M, Jacob J, Pulendran B (2007) Toll-like receptor expression and responsiveness of distinct murine splenic and mucosal B-cell subsets. PLoS ONE 2:e863.
27. Ha SA, et al. (2006) Regulation of B1 cell migration by signals through Toll-like receptors. J Exp Med 203:2541-2550.
28. Li J, et al. (2007) Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS. Microbiology 153:3141-3153.
29. Conlan JW, Vinogradov E, Monteiro MA, Perry MB (2003) Mice intradermally-inoculated with the intact lipopolysaccharide, but not the lipid A or O-chain, from Francisella tularensis LVS rapidly acquire varying degrees of enhanced resistance against systemic or aerogenic challenge with virulent strains of the pathogen. Microb Pathog 34:39-45.
30. Sebastian S, et al. (2009) Cellular and humoral immunity are synergistic in protection against types A and B Francisella tularensis.Vaccine 27:597-605.
31. Sebastian S, et al. (2007) A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity. Infect Immun 75:2591-2602.
32. Qureshi N, Takayama K, Ribi E (1982) Purification and structural determination of nontoxic lipid A obtained from the lipopolysaccharide of Salmonella typhimurium. J Biol Chem 257:11808-11815.
33. Elkins KL, Winegar RK, Nacy CA, Fortier AH (1992) Introduction of Francisella tularensis at skin sites induces resistance to infection and generation of protective immunity. Microb Pathog 13:417-421.